Trinity Capital Inc. (TRIN)
NASDAQ: TRIN · Real-Time Price · USD
14.42
-0.10 (-0.69%)
At close: Mar 13, 2026, 4:00 PM EDT
14.46
+0.04 (0.28%)
After-hours: Mar 13, 2026, 7:24 PM EDT
Trinity Capital Employees
Trinity Capital had 106 employees as of December 31, 2025. The number of employees increased by 18 or 20.45% compared to the previous year.
Employees
106
Change
18
Growth
20.45%
Revenue / Employee
$2,636,934
Profits / Employee
$1,279,283
Market Cap
1.20B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 106 | 18 | 20.45% |
| Sep 30, 2025 | 107 | 21 | 24.42% |
| Jun 30, 2025 | 95 | 12 | 14.46% |
| Mar 31, 2025 | 94 | 21 | 28.77% |
| Dec 31, 2024 | 88 | 20 | 29.41% |
| Sep 30, 2024 | 86 | 23 | 36.51% |
| Jun 30, 2024 | 83 | 22 | 36.07% |
| Mar 31, 2024 | 73 | 18 | 32.73% |
| Dec 31, 2023 | 68 | 11 | 19.30% |
| Sep 30, 2023 | 63 | 7 | 12.50% |
| Jun 30, 2023 | 61 | 9 | 17.31% |
| Mar 31, 2023 | 55 | 9 | 19.57% |
| Dec 31, 2022 | 57 | 16 | 39.02% |
| Sep 30, 2022 | 56 | 17 | 43.59% |
| Jun 30, 2022 | 52 | 13 | 33.33% |
| Mar 31, 2022 | 46 | 7 | 17.95% |
| Dec 31, 2021 | 41 | 7 | 20.59% |
| Sep 30, 2021 | 39 | 5 | 14.71% |
| Jun 30, 2021 | 39 | 9 | 30.00% |
| Mar 31, 2021 | 39 | 10 | 34.48% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
TRIN News
- 7 hours ago - Deploy Cash Now Into Double-Digit Yielding Passive Income - Seeking Alpha
- 2 days ago - Trinity Capital Inc. Provides $35 Million in Growth Capital to Monteris Medical to Support Neurosurgical Technology Advancements - PRNewsWire
- 3 days ago - TRINZ: To Refi Or Not To Refi (Rating Downgrade) - Seeking Alpha
- 3 days ago - Trinity Capital Inc. Provides $20 Million in Growth Capital to Emboline, Inc. to Advance Interventional Heart Procedure Technology - PRNewsWire
- 3 days ago - Emboline, Inc. Secures $20 Million in Growth Capital from Trinity Capital Inc. to Support Commercialization of the Emboliner® Embolic Protection System to Minimize Stroke Risk From TAVR - PRNewsWire
- 4 days ago - Trinity Capital Inc. Provides $35 Million in Growth Capital to Neuros Medical, Inc. to Scale Pain Management Therapy Adoption - PRNewsWire
- 7 days ago - 3 Things That Make You Delusional About BDCs - Seeking Alpha
- 10 days ago - Stop Panicking And Start Buying BDCs - Seeking Alpha